HK1128113A1 - Drug for cancer therapy - Google Patents

Drug for cancer therapy

Info

Publication number
HK1128113A1
HK1128113A1 HK09107583.9A HK09107583A HK1128113A1 HK 1128113 A1 HK1128113 A1 HK 1128113A1 HK 09107583 A HK09107583 A HK 09107583A HK 1128113 A1 HK1128113 A1 HK 1128113A1
Authority
HK
Hong Kong
Prior art keywords
drug
lactoferrin
cancer therapy
antibody
cancer
Prior art date
Application number
HK09107583.9A
Other languages
English (en)
Inventor
Kiyohiko Hatake
Yasuhito Terui
Yuji Mishima
Akio Yamada
Takuma Sakurai
Takehito Itoh
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1128113A1 publication Critical patent/HK1128113A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK09107583.9A 2004-03-19 2007-01-05 Drug for cancer therapy HK1128113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004080454 2004-03-19
HK07100198.3A HK1093436A1 (en) 2004-03-19 2007-01-05 Medicine for cancer therapy

Publications (1)

Publication Number Publication Date
HK1128113A1 true HK1128113A1 (en) 2009-10-16

Family

ID=34993444

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09107583.9A HK1128113A1 (en) 2004-03-19 2007-01-05 Drug for cancer therapy
HK07100198.3A HK1093436A1 (en) 2004-03-19 2007-01-05 Medicine for cancer therapy

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07100198.3A HK1093436A1 (en) 2004-03-19 2007-01-05 Medicine for cancer therapy

Country Status (14)

Country Link
US (1) US7419667B2 (xx)
EP (1) EP1726310B1 (xx)
JP (1) JP3998702B2 (xx)
KR (1) KR100773259B1 (xx)
CN (2) CN1838965B (xx)
AT (1) ATE541581T1 (xx)
AU (1) AU2005224209B2 (xx)
CA (1) CA2533753C (xx)
DK (1) DK1726310T3 (xx)
ES (1) ES2381189T3 (xx)
HK (2) HK1128113A1 (xx)
NZ (1) NZ544448A (xx)
PT (1) PT1726310E (xx)
WO (1) WO2005089788A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054908A1 (en) * 2004-11-19 2006-05-26 Fonterra Corporate Research And Development Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
WO2008075371A2 (en) * 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
RU2010114011A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение пептида yglf и сочетания с kvlpvpq
WO2010146578A2 (en) 2009-06-14 2010-12-23 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
EP2841084B1 (en) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
KR101455306B1 (ko) * 2012-07-17 2014-10-27 엘에스엠 주식회사 세포 증식 촉진용 사람 락토페린의 펩신 가수분해물 및 이의 제조 방법
CA2972397A1 (en) * 2014-10-08 2016-04-14 Nrl Pharma, Inc. Inhibitor of extracellular trap formation in leukocyte
EP3943098A3 (en) 2015-07-16 2022-05-11 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
MX2018004114A (es) 2015-10-06 2018-08-21 Univ Minnesota Compuestos terapeuticos y metodos.
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법
CN113354726B (zh) * 2021-06-11 2022-12-27 南方科技大学 乳铁蛋白活性肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351337A (ja) 1986-08-22 1988-03-04 Snow Brand Milk Prod Co Ltd 抗腫瘍剤
JPS63186260A (ja) 1987-01-28 1988-08-01 Minolta Camera Co Ltd 作像装置
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3110078B2 (ja) 1991-06-21 2000-11-20 森永乳業株式会社 高純度抗菌性ペプチドの大量製造法
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3207647B2 (ja) 1993-12-21 2001-09-10 森永乳業株式会社 ＩｇＧおよびＩｇＭクラスの抗体産生を促進する免疫賦活剤
JP3738042B2 (ja) 1994-05-17 2006-01-25 森永乳業株式会社 非経口用抗腫瘍剤
JP3506274B2 (ja) * 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JP3693377B2 (ja) 1995-04-20 2005-09-07 森永乳業株式会社 生体内で感染防御作用を有するペプチド混合物と、このペプチド混合物を含有する組成物
JPH1059864A (ja) 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
EP1017407A2 (en) * 1997-02-03 2000-07-12 Pharming Intellectual Property BV Useful properties of human lactoferrin and variants thereof
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
JP2000229881A (ja) 1999-02-10 2000-08-22 Morinaga Milk Ind Co Ltd 癌疾患の予後改善剤

Also Published As

Publication number Publication date
JP3998702B2 (ja) 2007-10-31
CN1838965B (zh) 2011-07-06
CA2533753C (en) 2012-10-16
EP1726310B1 (en) 2012-01-18
JPWO2005089788A1 (ja) 2008-01-31
CN101444624A (zh) 2009-06-03
CN1838965A (zh) 2006-09-27
EP1726310A4 (en) 2009-06-24
EP1726310A1 (en) 2006-11-29
NZ544448A (en) 2009-10-30
CN101444624B (zh) 2012-10-10
US20060204501A1 (en) 2006-09-14
HK1093436A1 (en) 2007-03-02
ES2381189T3 (es) 2012-05-23
KR100773259B1 (ko) 2007-11-05
PT1726310E (pt) 2012-04-27
AU2005224209B2 (en) 2007-04-19
KR20060095899A (ko) 2006-09-04
ATE541581T1 (de) 2012-02-15
CA2533753A1 (en) 2005-09-29
AU2005224209A1 (en) 2005-09-29
DK1726310T3 (da) 2012-05-07
US7419667B2 (en) 2008-09-02
WO2005089788A1 (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
HK1128113A1 (en) Drug for cancer therapy
HK1109876A1 (en) Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
PH12013502286A1 (en) Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
EP2331072A4 (en) METHODS AND COMPOSITIONS FOR ORAL PROTEIN DELIVERY
EP2175834B8 (en) Glp-1-fc fusion protein formulation
NZ605871A (en) Treatment of sanfilippo syndrome type b
WO2005000215A3 (en) Methods for treating pain
ES2194720T3 (es) Enzimas para el tratamiento de diabetes mellitus tipo i.
EA200801164A3 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
LT2529622T (lt) Brutono tirozinkinazės inhibitoriai
AR032392A1 (es) Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
WO2007087154A3 (en) Methods for enhancing therapeutic effects of a neurotoxin
WO2004074450A8 (en) Combination therapy for treating protein deficiencies
WO2003028757A1 (fr) Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes
WO2006067198A3 (en) Targeted use of engineered enzymes
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
WO2006134135A3 (en) Nutritional method for elderly people
DK1212410T3 (da) DNA kodende for den humane serinprotease EOS
WO2005116197A3 (en) Adamts-8 proteins and uses thereof
GEP20084378B (en) Composition with hepatoproective and metabolism normalizing activity
ZA200608865B (en) Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
ATE453388T1 (de) Calciumtrifluoroacetat zur bereitung antiangiogenetischer arzneimittel
AU2003262832A1 (en) Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170309